By the end of 2018, through 10 years of continuous research and development, we have successfully developed : Small molecule targeted anti-tumor products: 21 projects ,such as Gefitinib, Erlotinib, Pazopanib, Lapatinib, Afatinib, Lenvatinib,etc; Diabetes products: 16 items ,such as Sitagliptin, Linagliptin,Alogliptin, Dapagliflozin, and Canagliflozin,etc; Anti-Cardiovascular products: 7 projects ,including Apixaban, Rivaroxaban, Betrixaban, and Dofetilide;
ANQING CHICO PHARMACEUTICAL CO.,LTD.
Country: 
China (Mainland)
Business Type: Trading Company
Premiumsupplier
Ms.JIANG
Tel: +86-13057662806
(R)-5-bromo-3-(1-(2,6-dichloro-3-fluorophenyl)ethoxy)pyridin-2-amineCAS NO.: 877399-00-3
6-amino-4-[3-chloro-4-(2-pyridylmethoxy)anilino]-7-ethoxy-quinoline-3-carbonitrileCAS NO.: 848139-78-6
2-chloro-8-cyclopentyl-5-Methylpyrido[2,3-d]pyriMidin-7(8H)-oneCAS NO.: 1013916-37-4
4-Fluorobenzeneboronic acidCAS NO.: 1765-93-1
N-(Methoxycarbonyl)-L-valineCAS NO.: 74761-42-5
3-Amino-4-cyano-5-(4-phenoxyphenyl)pyrazoleCAS NO.: 330792-70-6
4-Methyl-1-(3-nitro-5-trifluoromethyl-phenyl)-1h-imidazoleCAS NO.: 916975-92-3
3-(2-chloropyriMidin-4-yl)-1-MethylindoleCAS NO.: 1032452-86-0
(3S)-3-(4-Aminophenyl)-1-piperidinecarboxylic acid 1,1-dimethylethyl esterCAS NO.: 1171197-20-8
Methyl 4-(5-(4-(pentyloxy)phenyl)isoxazol-3-yl)benzoateCAS NO.: 179162-64-2
